SearchSearch results for: “”

Stibbe has advised Aedifica on the further expansion of its healthcare real estate portfolio in the Netherlands with the acquisition and lease of 2 elderly care residences in Oss and Dordrecht.

Stibbe is representing Norsk Hydro, the world's leading aluminium and renewable energy company, in a series of mass damage claims.

Temper is an online platform that enables individuals to work as freelancers in various industries.

Stibbe advised and litigated for Sibelco/Eurogrit after small quantities of asbestos were found in the blasting grit they produce.

Fossielvrij NL has launched a greenwashing claim against Royal Dutch Airlines KLM, the first of its kind to be brought under the Dutch collective action regime.

Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.

Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Dordrecht and the acquisitions and leases of recently completed healthcare residences in Harderwijk and Berkel-Enschot (NL).

Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.

Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.

Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.

Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).

Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. 

Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). 

Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.

Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.

Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands.

Stibbe assisted a pharmaceutical multinational in complex litigations.

Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.